Comparing the current results to its competitors, Goodrx Holdings Inc reported Revenue decrease in the 2 quarter 2026 year on year by -1.31 %, despite the revenue increase by the most of its competitors of 27.62 %, recorded in the same quarter.
Goodrx Holdings Inc 's Comment on Competition and Industry Peers
The company operates in a competitive market that includes a range of prescription savings providers and pharmaceutical manufacturers. Competitors vary in size, including large e-commerce firms. The company has established an integrated savings program in partnership with several pharmacy benefit managers (PBMs) and has initiated direct contractual agreements with select pharmacies. Additionally, it has collaborated with a pharmaceutical manufacturer to offer reduced cash prices on GLP-1 medications. Competition spans prescription discounts, price comparison services, and pharmaceutical direct advertising and market access budget allocation.
June 4, 2024
In recent news, GoodRx Holdings, Inc. (NASDAQ: GDRX), a prominent player in the healthcare technology industry, finds itself entangled in a securities class action lawsuit. Rosen Law Firm, a trusted investor counsel, has urged investors to secure legal representation before the critical June 21, 2024 lead plaintiff deadline. The lawsuit pertains to the period between September 23, 2020, and November 8, 2022, during which purchasers of GoodRx common stock may have experienced detrimental effects.Additionally, Bragar Eagel and Squire, P.C., a well-known shareholder rights law firm, has notified investors about class action lawsuits against GoodRx Holdings, Inc. along with companies like Exscientia plc., Malibu...
May 26, 2024
In the realm of shareholder rights protection, Bragar Eagel and Squire, P.C. has emerged as a prominent law firm, standing up for investors interests. Recently, the firm has issued a reminder to investors about ongoing class action lawsuits concerning four companies: GoodRx Holdings, Inc., Exscientia plc., Malibu Boats, Inc., and Globe Life, Inc. Investors are encouraged to contact Bragar Eagel and Squire, P.C. for further information and potential inclusion as lead plaintiffs. This article aims to provide an overview of the ongoing class action lawsuits and the significance for investors.GoodRx Holdings, Inc. (NASDAQ: GDRX)GoodRx, an e-commerce platform that provides prescription price comparisons, is faci...
May 6, 2024
The esteemed global investor rights law firm, Rosen Law Firm, reiterates its call to shareholders of GoodRx Holdings, Inc. (NASDAQ: GDRX) to enlist legal counsel prior to the pivotal June 21, 2024 lead plaintiff deadline. In its role as a leading law firm, Rosen Law Firm is offering counsel regarding an impending securities class action that spans a period starting September 23, 2020, and culminates on November 8, 2022. This was a period of considerable volatility for purchasers of GoodRx common shares.Rosen Law Firm, well-known for its advocacy for investor rights and its track record of success, intends to guide investors of GoodRx Holdings through the imminent legal hurdles. Its agenda is to ensure invest...
May 2, 2024
New York-based Pomerantz Law Firm has initiated a legal storm against GoodRx Holdings, Inc., by announcing a class action lawsuit against the c...
Accolade Inc is a healthcare technology and services company that focuses on personalized advocacy. Their business model revolves around providing individuals with a single point of contact who helps navigate and optimize their healthcare experience, resulting in improved outcomes and reduced costs. They work closely with employers, health plans, and health systems to deliver these services and improve the overall healthcare experience for individuals.
Hims and Hers Health Inc's business model is centered around providing direct-to-consumer telehealth services for a wide range of health and wellness needs.
Sources:
Goodrx Holdings Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Goodrx Holdings Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
